DR. SUJUNG PARK M.D.
Prescription History 1811218621
Internal Medicine - Hematology & Oncology in Newark, DE
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SUJUNG PARK M.D., an active Hematology & Oncology specialist practicing in Newark, DE. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 795 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 171 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other DE PrescribersVs. DE Avg |
|---|---|---|---|
| Anastrozole | 171 | $44.35 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 171 Medicare prescriptions for Anastrozole, about 1.9 times the volume of the typical Delaware prescriber of this medication (87.7). Medicare paid an average of $44.35 per fill, versus $33.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 464.8 30-Day Fills standardized to 30-day supplies 13,893 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 71 | $9.25▼ below DE avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 71 Medicare prescriptions for Prochlorperazine Maleate, about 2.2 times the volume of the typical Delaware prescriber of this medication (32.2). Medicare paid an average of $9.25 per fill, versus $11.66 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 71 30-Day Fills standardized to 30-day supplies 654 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 67 | $6.42▼ below DE avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 67 Medicare prescriptions for Levothyroxine Sodium, about half the volume of the typical Delaware prescriber of this medication (136.5). Medicare paid an average of $6.42 per fill, versus $11.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 115 30-Day Fills standardized to 30-day supplies 3,437 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 51 | $11.73▼ below DE avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 51 Medicare prescriptions for Ondansetron Hcl, about 2 times the volume of the typical Delaware prescriber of this medication (26.1). Medicare paid an average of $11.73 per fill, versus $13.00 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 51 30-Day Fills standardized to 30-day supplies 615 Days of Medication total across all patients in 2024 | |||
| XareltoRivaroxaban | 45 | $950.58▼ below DE avg | ≈ Typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2024, this provider wrote 45 Medicare prescriptions for Xarelto, about 78% of the volume of the typical Delaware prescriber of this medication (57.7). Medicare paid an average of $950.58 per fill, versus $1,099.59 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 73 30-Day Fills standardized to 30-day supplies 2,190 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 42 | $11.38▼ below DE avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 42 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical Delaware prescriber of this medication (80.7). Medicare paid an average of $11.38 per fill, versus $15.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 42 30-Day Fills standardized to 30-day supplies 514 Days of Medication total across all patients in 2024 | |||
| Exemestane | 36 | $119.10▼ below DE avg | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 36 Medicare prescriptions for Exemestane, about 1.5 times the volume of the typical Delaware prescriber of this medication (23.3). Medicare paid an average of $119.10 per fill, versus $133.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,197 Days of Medication total across all patients in 2024 | |||
| Prednisone | 33 | $9.18 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 33 Medicare prescriptions for Prednisone, about 68% of the volume of the typical Delaware prescriber of this medication (48.9). Medicare paid an average of $9.18 per fill, versus $4.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,186 Days of Medication total across all patients in 2024 | |||
| Lidocaine Hcl ViscousLidocaine Hcl | 30 | $27.66 | ▲ More than typical |
About Lidocaine Hcl Viscous: See also Warning section. Show more ▾ Viscous lidocaine is used to relieve pain and discomfort from a sore throat/mouth. It is also used to numb the lining of the mouth and throat before certain medical/dental procedures (such as dental impressions). This numbing helps prevent the urge to close the throat (gag reflex), which might make the procedure more difficult. Lidocaine belongs to a class of drugs known as local anesthetics. A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. In 2024, this provider wrote 30 Medicare prescriptions for Lidocaine Hcl Viscous, about 1.8 times the volume of the typical Delaware prescriber of this medication (16.5). Medicare paid an average of $27.66 per fill, versus $16.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 180 Days of Medication total across all patients in 2024 | |||
| VerzenioAbemaciclib | 23 | $15,538.15▼ below DE avg | ≈ Typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A cell cycle inhibitor. In 2024, this provider wrote 23 Medicare prescriptions for Verzenio, about the same volume as the typical Delaware prescriber of this medication (21). Medicare paid an average of $15,538.15 per fill, versus $15,585.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 23 | $35.94▼ below DE avg | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 23 Medicare prescriptions for Tamoxifen Citrate, about 69% of the volume of the typical Delaware prescriber of this medication (33.2). Medicare paid an average of $35.94 per fill, versus $37.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 59 30-Day Fills standardized to 30-day supplies 1,745 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 22 | $9.22▼ below DE avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 22 Medicare prescriptions for Alendronate Sodium, about half the volume of the typical Delaware prescriber of this medication (42.4). Medicare paid an average of $9.22 per fill, versus $10.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 49 30-Day Fills standardized to 30-day supplies 1,456 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 21 | $12,785.71▼ below DE avg | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 21 Medicare prescriptions for Lenalidomide, about 64% of the volume of the typical Delaware prescriber of this medication (32.8). Medicare paid an average of $12,785.71 per fill, versus $13,932.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 21 30-Day Fills standardized to 30-day supplies 553 Days of Medication total across all patients in 2024 | |||
| Tramadol Hcl | 20 | $14.74 | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2024, this provider wrote 20 Medicare prescriptions for Tramadol Hcl, about half the volume of the typical Delaware prescriber of this medication (46.9). Medicare paid an average of $14.74 per fill, versus $7.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 19 | $10.02▼ below DE avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 19 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical Delaware prescriber of this medication (82.8). Medicare paid an average of $10.02 per fill, versus $17.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 28.1 30-Day Fills standardized to 30-day supplies 843 Days of Medication total across all patients in 2024 | |||
| Mirtazapine | 19 | $6.94▼ below DE avg | ▼ Less than typical |
About Mirtazapine: This medication is used to treat depression. Show more ▾ Mirtazapine works by helping to restore the balance of certain natural substances in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2024, this provider wrote 19 Medicare prescriptions for Mirtazapine, about half the volume of the typical Delaware prescriber of this medication (43). Medicare paid an average of $6.94 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2024 | |||
| Acyclovir | 19 | $31.15 | ▼ Less than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2024, this provider wrote 19 Medicare prescriptions for Acyclovir, about 72% of the volume of the typical Delaware prescriber of this medication (26.3). Medicare paid an average of $31.15 per fill, versus $21.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 17 | $28.81 | ≈ Typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 17 Medicare prescriptions for Ondansetron Odt, about 81% of the volume of the typical Delaware prescriber of this medication (21). Medicare paid an average of $28.81 per fill, versus $16.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 170 Days of Medication total across all patients in 2024 | |||
| CalquenceAcalabrutinib Maleate | 14 | $15,307.64 | ≈ Typical |
About Calquence: This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Show more ▾ Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Inhibits Bruton’s tyrosine kinase; has antineoplastic activity. In 2024, this provider wrote 14 Medicare prescriptions for Calquence, about 75% of the volume of the typical Delaware prescriber of this medication (18.6). Medicare paid an average of $15,307.64 per fill, versus $14,084.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 13 | $739.86▼ below DE avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 13 Medicare prescriptions for Eliquis, about 15% of the volume of the typical Delaware prescriber of this medication (89.2). Medicare paid an average of $739.86 per fill, versus $1,046.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 13 | $13.19▼ below DE avg | ▼ Less than typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 13 Medicare prescriptions for Dexamethasone, about half the volume of the typical Delaware prescriber of this medication (26). Medicare paid an average of $13.19 per fill, versus $13.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 19 30-Day Fills standardized to 30-day supplies 458 Days of Medication total across all patients in 2024 | |||
| Alprazolam | 13 | $1.54▼ below DE avg | ▼ Less than typical |
About Alprazolam: Alprazolam is used to treat anxiety and panic disorders. Show more ▾ It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA). A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) In 2024, this provider wrote 13 Medicare prescriptions for Alprazolam, about a quarter of the volume of the typical Delaware prescriber of this medication (59.6). Medicare paid an average of $1.54 per fill, versus $7.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DE average for this medication. 15 30-Day Fills standardized to 30-day supplies 305 Days of Medication total across all patients in 2024 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $5.80 | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 13 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about half the volume of the typical Delaware prescriber of this medication (25.8). Medicare paid an average of $5.80 per fill, versus $4.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.5 30-Day Fills standardized to 30-day supplies 448 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. SUJUNG PARK M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Newark, DE practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DE prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
